So in summary, HER2CLIMB-05 was a positive study. It showed that adding tucatinib for both HR-positive as well as HR-negative ...

As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.

As of Monday, December 22, TryHard Holdings Limited’s THH share price has surged by 12.74%, which has investors questioning if this is right time to sell.

Overall, 71.8% (61.5% confirmed) of patients had partial responses to either of two dose levels of pumitamig plus ...

Consumer Guide to Evaluating LottoChamp AI Tool Claims, FTC Disclosure Standards, and Lottery Odds Reality for 2026 ...

Data from the PREFER study—a large, multicenter prospective cohort in Italy—show that while most premenopausal women with early breast cancer opted for GnRHa therapy to protect their ovaries during ...

Long-term data published in JAMA Neurology further illustrate the effects of Biogen’s QALSODY on function, strength, and survival in SOD1-ALSOver ...

Silverback Digital Marketing has announced a continued focus on refining its social media marketing practices, reflecting ...

Dual art therapy, combining music and painting, significantly improved symptoms, cognitive function, and quality of life in ...

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following oral administration. MIAMI, FL / ACCESS Newswire / December 18, 2025 / ...

This population-based study used plasma pTau217 to estimate how common Alzheimer’s disease neuropathological changes are across age and cognitive status in a Norwegian community cohort. Prevalence ...